List view / Grid view
22 October 2015 | By Victoria White
The Amgen Biotech Experience was designed to inspire the next generation of innovators and give school students the opportunity to experience real science...
21 October 2015 | By Kate Douetil
This innovative new global investment fund has gained support from a wide variety of investors, including the UK Government’s Department of Health (DoH), Alzheimer’s Research UK and world-leading major pharmaceutical companies Biogen, GlaxoSmithKline, Johnson & Johnson, Lilly, Pfizer and Takeda...
21 October 2015 | By Victoria White
The investigational aerosol vaccine protected rhesus macacques from pulmonary TB infection better than the similarly delivered BCG vaccine...
21 October 2015 | By Victoria White
The research team have changed how the genome is folded inside the nucleus. The advance may lead to new methods of understanding and overcoming genetic diseases...
21 October 2015 | By Victoria White
BBI has acquired an exclusive global license for the clinical development and commercialisation of the vaccines...
20 October 2015 | By Victoria White
Domainex has been selected as Imperial’s strategic drug discovery partner to provide services including biochemical and biophysical assay development...
20 October 2015 | By Victoria White
Researchers found that when HIFalpha was ‘switched off’, nerve function in flies with Parkinson’s disease was restored...
20 October 2015 | By Victoria White
The surprise finding could lead to a powerful new therapy for leukaemia and possibly other cancers...
19 October 2015 | By Victoria White
Preclinical data demonstrate the effectiveness of VAL-083 against cisplatin-resistant ovarian cancers...
19 October 2015 | By Victoria White
Earlier this year, Inovio’s MERS vaccine induced 100% protection from a live virus challenge in a preclinical study...
19 October 2015 | By Victoria White
Pyroglutamate-3 Abeta (pGlu-3 Abeta), a post-translational modified Abeta, is a highly toxic Abeta variant which is abundant in brains of patients with Alzheimer’s disease...
19 October 2015 | By Victoria White
Genomics has entered into a collaboration agreement in a research project focused on the translation of whole genome sequencing into clinical practice...
19 October 2015 | By Victoria White
Within the framework of the collaboration, Nuevolution will apply its drug discovery platform Chemetics to discover and advance drug candidates...
16 October 2015 | By Victoria White
The research raises the possibility that testing of those most at risk of the disorder could allow them to be treated early enough to avoid the disorder's most severe symptoms...
16 October 2015 | By Victoria White
The scientists used novel genetic engineering tools to manipulate the genes required for antibiotic biosynthesis...
